Global Venous Stents Market Report and Forecast 2024-2032

Global Venous Stents Market Size

The global venous stents market was valued at USD 1.10 billion in 2023, driven by increasing incidence of venous diseases across the globe. The market is expected to grow at a CAGR of 8.45% during the forecast period of 2024-2032, with the values likely to reach USD 2.29 billion by 2032.

Global Venous Stents Market Outlook

• The demand for venous stents is on the rise driven by increasing preference for non-invasive procedures.

• One of the major market trends includes the adoption of advanced technologies to improve procedure success rates and patient outcomes.

• North America region is expected to experience notable growth in the forecast period. Advanced healthcare infrastructure and increased public awareness is projected to boost the market value.

Global Venous Stents Market Overview

Venous stents are metal mesh-like tubes that expand against narrowed or blocked vein walls in order to maintain the blood flow. These stents are used in the treatment of conditions like chronic venous insufficiency (CVI) and deep vein thrombosis (DVT) to ensure proper blood flow through the affected vein. The market is driven by increasing advancements in venous stent design, rising healthcare expenditure and initiatives to boost awareness around early detection of diseases across the globe.

Global Venous Stents Market Growth Drivers

Increasing Prevalence of Venous Diseases to Affect the Market Landscape Significantly

The increase in prevalence of venous diseases like deep vein thrombosis, venous thromboembolism, and May-Thurner syndrome among others which can be attributed to lifestyle changes and increasing obesity cases in the population is driving growth for venous stents. The economic burden of the disease is also significant due to the cost of medical care.

Adoption of Wallstent Technology to Meet Rising Venous Stents Market Demand

With a rising need to combat venous diseases, the market is witnessing several innovations in products and technology to offer improved solutions to patients. Self-expending stents are taking over the market with the products like Vici, Venovo Venous Stent System, and Abre Venous Self-Expanding Stent System launched by the major market players. Wallstent technology offers multiple advantages such as reduction in complications, improved central venous luminal diameter and provides treatment of symptomatic venous outflow obstruction. Venous Wallstent provides compression resistance as well as fracture resistance. The integration of such technologies is expected to drive market growth and provide a better quality of life to patients.

Global Venous Stents Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Global Venous Stents Market Segmentation

Market Breakup by Technology

• Iliac Vein Stent Technology

• Wallstent Technology

• Others

Market Breakup by Indication

• Chronic Deep Vein Thrombosis

• Post Thrombotic Syndrome

• May-Thurner Syndrome

• Pelvic Congestion Syndrome (PCS)

• Others

Market Breakup by Application

• Leg

• Chest

• Abdomen

• Others

Market Breakup by End User

• Hospitals

• Ambulatory Surgery Centers

• Specialty Clinics

• Cardiac Catheterization Labs

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Venous Stents Market Share

Wallstent Technologies Expected to Lead the Market Share Based on Technology

Based on technology, the market segmentation includes iliac vein stent technology, wallstent technology, and others. Wallstent technology is popular for its high adaptability as well as structural flexibility to venous anatomy and holds a notable market share. Iliac vein stent technology is experiencing rapid growth. The growth is propelled by its vital role in treatment of iliac vein obstruction. It is further fueled by advancements in imaging technologies and procedural techniques which enhances safety and precision of stent placements.

Market Segmentation Based on Disease Areas is Anticipated to Witness Substantial Growth

Based on disease, the market constitutes acute deep vein thrombosis (DVT), chronic DVT/ post-thrombotic syndrome (PTS), non-thrombotic iliac vein lesions (NIVL)/May-Thurner Syndrome (MTS) among others. Out of these, acute DVT is estimated to hold a significant market share. NIVL/MTS is also projected to witness substantial growth, owing to advancements in diagnostic technology which are enhancing the specificity of treatment for the condition. As awareness regarding this conditions rise, the demand for specialized stents is also expected to increase.

Global Venous Stents Market Analysis by Region

On the basis of region, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America boasts an advanced healthcare infrastructure along with presence of key healthcare companies. As a result, it leads the market share. In addition, investments in research and development and medical devices are boosting this region’s market growth. Europe follows closely, with growth driven by governmental support for healthcare innovations and growing prevalence of venous conditions. Focus on improving healthcare outcomes and adoption of new technologies are the major factors for the market’s expansion.

Leading Players in the Global Venous Stents Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbott Laboratories

• Becton, Dickinson and Company

• Bentley

• Boston Scientific Corporation

• Cardinal Health

• Cook Group Incorporated

• Koninklijke Philips N.V.

• Medtronic

• W.L Gore & Associates, Inc.

• Shanghai MicroPort Endovascular MedTech (Group)Co., Ltd.

• Jotec GmbH

• Optimed Medizinische Instrumente GmbH

• MicroPort Scientific Corporation

• Medica Germany GMBH & Co.KG

• Cordis Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Venous Stents Market Report Snapshots

Venous Stents Market Size

Venous Stents Market Growth

Venous Stents Market Trends

Venous Stents Market Share

Venous Stents Regional Analysis

Venous Stents Companies

Key Questions Answered in the Global Venous Stents Market Report

• What was the global venous stents market value in 2023?
• What is the global venous stents market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report? 
• What is market segmentation based on indication?
• Who are the major end users in the market?
• What type of technologies are present in the market?
• Where does venous stents find its application?
• What are the major factors aiding the global venous stents market demand? 
• How has the market performed so far and how is it anticipated to perform in the coming years?
• What are the major market trends influencing the market? 
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• How does the prevalence and incidence of cardiovascular diseases affect the market landscape?
• How does the rise in the geriatric population impact the market size?
• What disease will dominate the market share? 
• Which application area is expected to have a high market value in the forecast period?
• Which technology type will experience the highest demand in the market segment?
• Who are the key players involved in the venous stents market?
• What is patent landscape of the market? 
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?